Search Results 591-600 of 18082 for Tuberculosis

  1. A Study to Assess the Safety and Pharmacokinetics of Subcutaneously Administered Golimumab, a Human Anti-TNFα Antibody, in Pediatric Patients With Moderate to Severe Active Ulcerative Colitis - Mayo Clinic

    No history of latent or active tuberculosis prior to screening; Positive protective antibody titers to varicella and measles prior to the first ...

  2. HIV/AIDS - Symptoms and causes - Mayo Clinic

    Tuberculosis, also called TB. TB is a common opportunistic infection linked to HIV . Worldwide, TB is a leading cause of death among people with AIDS . It's ...

  3. Efavirenz, emtricitabine, and tenofovir (oral route) - Side effects & dosage - Mayo Clinic

    Sometimes the immune system will start to fight infections that were hidden in your body, such as pneumonia, herpes, or tuberculosis. Autoimmune disorders ...

  4. Cirrhosis - Doctors and departments - Mayo Clinic

    Mayo researchers were among the first to identify nonalcoholic fatty liver disease and primary sclerosing cholangitis. Mayo researchers are also making ...

  5. Cosentyx (Secukinumab) for the Treatment of Adult Onset Pityriasis Rubra Pilaris - Mayo Clinic

    Known history of hepatitis B, hepatitis C, or tuberculosis; Personal or family history of inflammatory bowel disease. Participating Mayo Clinic locations.

  6. Infectious Diseases - 2021 Archives - Page 20 of 26

    When will kids be eligible to be vaccinated for COVID-19? Jason Howland. March 26, 2021. World TB Day: Tuberculosis remains a ...

  7. Staph infections - Doctors and departments - Mayo Clinic

    Infectious Disease Specialist. Rochester, MN. Areas of focus: Infection control, General infectious diseases, Staph infections, Tuberculosis, Bacterial ...

  8. A Study of CYP-001 in Combination With Corticosteroids in Adults With High-risk aGvHD - Mayo Clinic

    ability of the subject to participate in the trial. - Known infection with CMV, EBV, HHV-6, HBV, HCV, HIV or Tuberculosis. If the treatment for CMV, EBV ...

  9. A Study of Pembrolizumab (MK-3475) Versus Placebo in Combination with Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer - Mayo Clinic

    Has a known history of active tuberculosis (Bacillus tuberculosis). Has an active infection requiring systemic therapy. Has a history or current evidence of ...

  10. Trial to Evaluate Efficacy and Safety of Lenabasum in Dermatomyositis - Mayo Clinic

    History of active tuberculosis or positive tuberculosis test without a completed course of appropriate treatment. Having already completed at least 1 month ...